ID: MRFR/MED/0979-HCR | February 2021 | Region: Global | 80 pages
Apheresis Market scenario:
Apheresis is the medical technology which is used for the purification of the blood or separation of different component of blood. It involves removing of the blood from the donor or patients and collecting it into an apparatus which separates the desired component from the blood, while the rest of the blood is send back to the donor or patients. This separation of the component was done by two process namely centrifugation and filtration. Global apheresis market is driven by development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases and many more. Increasing demand for the different component of the bloods, rising complex surgical procedures and increasing number of accidents across the globe has also contributed in the growth of the market. According to National Health Service (NHS) Blood and Transplant, the demand for platelets. While lack of skilled professional and Blood and blood product can be infected very easily, this risk of infection also contribute in hindering the market growth.
Apheresis Market is increasing at a rapid pace which is expected to grow at a CAGR of 10.2% during forecasted period 2017-2023.
Apheresis Market Segmentation:
Global apheresis market is segmented on the basis of product into devices and disposables. Devices are further segmented into plasma separators, platelets separators and other. On the basis of procedures, they are plateletpheresis, leukapheresis, erythrocytapheresis, plasmapheresis and other. On the basis of methods they are centrifugation and filtration. Centrifugation is further segmented into continuous flow centrifugation, intermittent flow centrifugation and other. On the basis of application, the market is segmented into oncological diseases, renal diseases, cardiovascular diseases, haematological diseases, immunological diseases, neurological diseases and other and on the basis of end user they are blood banks, hospitals and other.
Study Objectives Global Apheresis Market:
Detail analysis of global apheresis market with region specific growth and competitive analysis on the basis of major players present in the market
Detail analysis of global apheresis market and different drivers and restraints affecting the growth of the market
Detailed analysis of the historical and forecasted market analysis of the market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global apheresis
Detail analysis on the possible segments and sub segments of the market. And regional analysis of the market- Americas, Europe, Asia Pacific and Middle East and Africa.
Insights on the major countries/regions in which these major industries is flourishing and to also identify the untapped regions which could be the potential markets in future
On regional basis, Americas hold the largest share in the global apheresis market. Continuous advance in technology, increasing opportunity for apheresis products and presence of a huge number of people suffering from different chronic diseases has spurred the growth of this market in Americas. Europe is the second leading market which is followed by Asia Pacific. However Asia Pacific is the fastest growing region for the market. Increasing demand for different blood components for the patients, rapid development in healthcare and increasing healthcare expenditure are contributing in the growth of Asia Pacific apheresis market.
Key Players For Global Apheresis Market:
Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).
The report for global apheresis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Frequently Asked Questions (FAQ) :
Global Apheresis Market can expand at 10.2% CAGR from 2017 to 2023.
Increasing prevalence of blood diseases and advances in apheresis equipment can drive the Global Apheresis Market.
Lack of skilled professionals and probability of infections with equipment are concerns of the Global Apheresis Market.
Americas can dominate the Global Apheresis Market till 2023.
Kawasumi Laboratories Inc., Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Terumo BCT, Inc., Fresenius Medical Care, Haemonetics Corporation, Nikkiso Co., Ltd., Kaneka Corporation, Cerus Corporation, HemaCare Corporation, and Therakos, Inc. are major players of the Global Apheresis Market.
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL APHERESIS MARKET, BY PRODUCT
5.1.1 PLASMA SEPARATORS
5.1.2 PLATELETS SEPARATORS
6. GLOBAL APHERESIS MARKET, BY PROCEDURES
7. GLOBAL APHERESIS MARKET, BY METHODS
7.1.1 CONTINUOUS FLOW CENTRIFUGATION
7.1.2 INTERMITTENT FLOW CENTRIFUGATION
8. GLOBAL APHERESIS MARKET, BY APPLICATION
8.1 ONCOLOGICAL DISEASES
8.2 RENAL DISEASES
8.3 CARDIOVASCULAR DISEASES
8.4 HAEMATOLOGICAL DISEASES
8.5 IMMUNOLOGICAL DISEASES
8.6 NEUROLOGICAL DISEASES
9. GLOBAL APHERESIS MARKET, BY END USERS
9.1 BLOOD BANKS
10. GLOBAL APHERESIS MARKET, BY REGION
10.2.1 NORTH AMERICA
10.2.2 SOUTH AMERICA
10.3.1 WESTERN EUROPE
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4.5 REPUBLIC OF KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 UNITED ARAB EMIRATES
10.5.2 SAUDI ARABIA
10.5.6 REST OF MIDDLE EAST & AFRICA
11. COMPETITIVE LANDSCAPE
11.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
11.1.1 STRATEGIC PARTNERSHIP
11.1.2 MERGER & ACQUISITION
12 COMPANY PROFILE
12.1 HAEMONETICS CORPORATION
12.1.2 PRODUCT OVERVIEW
12.1.4 KEY DEVELOPMENTS
12.2 FRESENIUS MEDICAL CARE
12.2.2 PRODUCT OVERVIEW
12.2.4 KEY DEVELOPMENTS
12.3 TERUMO BCT, INC
12.3.2 PRODUCT OVERVIEW
12.3.5 KEY DEVELOPMENT
12.4 ASAHI KASEI MEDICAL CO. LTD
12.4.2 PRODUCT OVERVIEW
12.4.4 KEY DEVELOPMENTS
12.5 HEMACARE CORPORATION
12.5.2 PRODUCT OVERVIEW
12.5.4 KEY DEVELOPMENTS
12.6 B. BRAUN MELSUNGEN AG
12.6.2 PRODUCT OVERVIEW
12.6.4 KEY DEVELOPMENTS
12.7 CERUS CORPORATION
12.7.2 PRODUCT OVERVIEW
12.7.4 KEY DEVELOPMENTS
14.1 KEY FINDINGS
14.1.1 FROM CEO’S VIEWPOINT
14.1.2 UNMET NEEDS OF THE MARKET
14.2 KEY COMPANIES TO WATCH
14.3 PREDICTION OF APHERESIS INDUSTRY